The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer

Recruiting Observational Study
Pancreatic Adenocarcinoma
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Medical University of Vienna · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to validate a pretreatment prognostic score (Heidelberg Prognostic Pancreatic Cancer Score - HELPP) in patients with pancreatic ductal adenocarcinoma. The main questions it aims to answer are: * Is the HELPP score able to predict median overall survival in a prospective multi-institutional cohort of patients with pretherapeutic localized non-metastatic pan…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ≥18 years old * fit to undergo elective pancreatic resection or palliative therapy * localized non-metastatic pancreatic ductal adenocarcinoma * informed consent provided Exclusion Criteria: * patients with a diagnosis other than pancreatic ductal adenocarcinoma on histopath…
Contacts

Carl Leonhardt, MD MBA

+43140400

carl-stephan.leonhardt@meduniwien.ac.at

CONTACT